These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34452253)

  • 1. Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery.
    Quagliarini E; Renzi S; Digiacomo L; Giulimondi F; Sartori B; Amenitsch H; Tassinari V; Masuelli L; Bei R; Cui L; Wang J; Amici A; Marchini C; Pozzi D; Caracciolo G
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Insights into the Superior DNA Delivery Efficiency of Multicomponent Lipid Nanoparticles: An In Vitro and In Vivo Study.
    Quagliarini E; Wang J; Renzi S; Cui L; Digiacomo L; Ferri G; Pesce L; De Lorenzi V; Matteoli G; Amenitsch H; Masuelli L; Bei R; Pozzi D; Amici A; Cardarelli F; Marchini C; Caracciolo G
    ACS Appl Mater Interfaces; 2022 Dec; 14(51):56666-56677. PubMed ID: 36524967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
    Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Delivery of DNA Using Lipid Nanoparticles.
    Cui L; Renzi S; Quagliarini E; Digiacomo L; Amenitsch H; Masuelli L; Bei R; Ferri G; Cardarelli F; Wang J; Amici A; Pozzi D; Marchini C; Caracciolo G
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.
    Lopes C; Cristóvão J; Silvério V; Lino PR; Fonte P
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1381-1395. PubMed ID: 36223174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
    Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
    AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
    Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M
    J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing.
    Sarode A; Fan Y; Byrnes AE; Hammel M; Hura GL; Fu Y; Kou P; Hu C; Hinz FI; Roberts J; Koenig SG; Nagapudi K; Hoogenraad CC; Chen T; Leung D; Yen CW
    Nanoscale Adv; 2022 May; 4(9):2107-2123. PubMed ID: 36133441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.
    Konca YU; Kirshenbaum K; Zuckermann RN
    Int J Nanomedicine; 2014; 9():2271-85. PubMed ID: 24872690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based Nanoparticles.
    Giulimondi F; Digiacomo L; Renzi S; Cassone C; Pirrottina A; Molfetta R; Palamà IE; Maiorano G; Gigli G; Amenitsch H; Pozzi D; Zingoni A; Caracciolo G
    ACS Appl Bio Mater; 2024 Jun; 7(6):3746-3757. PubMed ID: 38775109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics.
    Roces CB; Lou G; Jain N; Abraham S; Thomas A; Halbert GW; Perrie Y
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33203082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.
    Maeki M; Fujishima Y; Sato Y; Yasui T; Kaji N; Ishida A; Tani H; Baba Y; Harashima H; Tokeshi M
    PLoS One; 2017; 12(11):e0187962. PubMed ID: 29182626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the mechanism of action of DNA-loaded PEGylated lipid nanoparticles.
    Digiacomo L; Renzi S; Quagliarini E; Pozzi D; Amenitsch H; Ferri G; Pesce L; De Lorenzi V; Matteoli G; Cardarelli F; Caracciolo G
    Nanomedicine; 2023 Sep; 53():102697. PubMed ID: 37507061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy.
    Wilhelmy C; Keil IS; Uebbing L; Schroer MA; Franke D; Nawroth T; Barz M; Sahin U; Haas H; Diken M; Langguth P
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device.
    Maeki M; Okada Y; Uno S; Niwa A; Ishida A; Tani H; Tokeshi M
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection.
    Thomas A; M Garg S; De Souza RAG; Ouellet E; Tharmarajah G; Reichert D; Ordobadi M; Ip S; Ramsay EC
    Methods Mol Biol; 2018; 1792():193-203. PubMed ID: 29797261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
    M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing.
    El-Mayta R; Padilla MS; Billingsley MM; Han X; Mitchell MJ
    J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.